BCAX · Bicara Therapeutics Inc. Common Stock

Summary

Bicara Therapeutics Inc. issued a press release on February 19, 2026, announcing that Ficerafusp Alfa 2000mg Q2W demonstrates deep, durable responses. The filing includes Exhibit 99.1, the press release, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

Key takeaways

• Press release issued on February 19, 2026
• Ficerafusp Alfa 2000mg Q2W demonstrates deep, durable responses
• Exhibit 99.1: Press Release dated February 19, 2026
• Reported under Item 8.01 Other Events